Low-dose Cytosine arabinoside; disease free survival and overall survival in the elderly patients with Acute Myeloid Leukemia

被引：0
作者：
Sanaat, Zohreh [1 ]
Najafi, Amin [1 ]
机构：
[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Ghazi Tabatabae Hosp, Tabriz, Iran
来源：
PAKISTAN JOURNAL OF MEDICAL SCIENCES | 2011年 / 27卷 / 05期
关键词：
Acute myeloid leukemia; Low-dose Cytosine arabinoside; Disease-free survival; Overall survival; Flowcytometry; Elderly AML; ACUTE NONLYMPHOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; ARA-C; CYTARABINE; THERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objectives: The median age of the patients with acute myeloid leukemia (AML) is 65 years. Studies have revealed that the prognosis of the elderly patients (over 60 years) is not satisfying. The aim of this study was to evaluate the survival of AML patients being treated with Low-dose Cytosine arabinoside. Methodology: In this cross-sectional study, 20 AML patients treated with Low-dose Cytosine arabinoside. Disease free survival and overall five-year survival ratios were identified. Results: In this study there were 11 males (55%) and nine female (45%) with a mean age of 63.3 +/- 18.4 years. The median of disease free survival was 12.4 months and five-year survival was 1.7 years. Conclusion: Apparently disease-free survival and overall five-year survival in the AML patients being treated with Low-dose Cytosine arabinoside are similar to that of cases being treated with intense chemotherapy regimens.
引用
收藏
页码：1211 / 1213
页数：3
相关论文
共 50 条
[41]   An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure [J].
Swan Lin ;
Naveed Shaik ;
Geoffrey Chan ;
Jorge E. Cortes ;
Ana Ruiz-Garcia .
Cancer Chemotherapy and Pharmacology, 2020, 86 :451-459
[42]   Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy [J].
Taenaka, Ryutaro ;
Obara, Teppei ;
Kohno, Kentaro ;
Aoki, Kenichi ;
Ogawa, Ryosuke .
INTERNAL MEDICINE, 2023, 62 (05) :689-695
[43]   An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure [J].
Lin, Swan ;
Shaik, Naveed ;
Chan, Geoffrey ;
Cortes, Jorge E. ;
Ruiz-Garcia, Ana .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) :451-459
[44]   Arsenic Trioxide and Low-dose Cytarabine in Older Patients With Untreated Acute Myeloid Leukemia, Excluding Acute Promyelocytic Leukemia [J].
Roboz, Gail J. ;
Ritchie, Ellen K. ;
Curcio, Tania ;
Provenzano, Juliette ;
Carlin, Rebecca ;
Samuel, Michael ;
Wittenberg, Beth ;
Mazumdar, Madhu ;
Christos, Paul J. ;
Mathew, Susan ;
Allen-Bard, Sandra ;
Feldman, Eric J. .
CANCER, 2008, 113 (09) :2504-2511
[45]   Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI [J].
Othus, Megan ;
van Putten, Wim ;
Lowenberg, Bob ;
Petersdorf, Stephen H. ;
Nand, Sucha ;
Erba, Harry ;
Appelbaum, Frederick ;
Hills, Robert ;
Russell, Nigel ;
Burnett, Alan ;
Estey, Elihu .
HAEMATOLOGICA, 2016, 101 (07) :284-286
[46]   Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML [J].
Kantarjian, Hagop M. ;
Sekeres, Mikkael A. ;
Ribrag, Vincent ;
Rousselot, Philippe ;
Garcia-Manero, Guillermo ;
Jabbour, Elias J. ;
Owen, Kate ;
Stockman, Paul K. ;
Oliver, Stuart D. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (05) :559-567
[47]   PATTERN OF LIVER-DISEASE FOLLOWING HIGH-DOSE CYTOSINE-ARABINOSIDE (HDARAC) THERAPY IN CHILDREN WITH ACUTE MYELOID-LEUKEMIA [J].
LOCASCIULLI, A ;
UDERZO, C ;
PIROLA, A ;
MASERA, G ;
PORTMANN, B ;
ALBERTI, A .
LEUKEMIA & LYMPHOMA, 1990, 2 (3-4) :229-233
[48]   Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells [J].
Chen, Liyun ;
Guo, Pei ;
Zhang, Yunxiang ;
Li, Xiaoyang ;
Jia, Peimin ;
Tong, Jianhua ;
Li, Junmin .
LEUKEMIA RESEARCH, 2017, 60 :44-52
[49]   High-dose cytosine arabinoside in the treatment of acute myeloid leukemia - Review of three randomized trials [J].
Kern, Wolfgang ;
Estey, Elihu H. .
CANCER, 2006, 107 (01) :116-124
[50]   INTERFERON-ALPHA PLUS LOW-DOSE CYTOSINE-ARABINOSIDE IN ADVANCED PHASE CHRONIC MYELOGENOUS LEUKEMIA PATIENTS [J].
FERRAJOLI, A ;
LIBERATI, AM ;
CARICCHI, P ;
DONTI, E ;
MORRA, E ;
LAZZARINO, M ;
BETTI, AR ;
BERNASCONI, P ;
SAGLIO, G .
EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 55 (03) :184-188
12345